LSRN
Maitland, Florida, 32751, United States
Location status: Recruiting
NCT Number: NCT07660354
To compare the safety, effectiveness, and preventive benefits of a medical device (X92001483) against Nix Cream Rinse (1% Permethrin) in people with head lice
Interested in participating?
Request Info1 year and older
All sexes
Interventional
Not applicable
Maitland, Florida, 32751, United States
Location status: Recruiting
Compare Safety, Efficacy and preventative effect of a medical device with a physical mode of action against Nix Cream Rinse (1% Permethrin) in Subjects with Head Lice in a two-arm, randomized, controlled, Investigator/Assessor-blinded comparative study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Treatment of subjects with Head Lice with a medical device (X92001483) with a physical mode of action on day 0, day 7, day 10, day 13 and day 14.
Time frame: 14 days
Determin whether subjects treated with the medical device X92001943 after treatment with Nix Creme Rinse maintain a higher cure rate at the end of the study compared with subjects treated only with Nix Creme Rinse.
Time frame: day 3, day 7, day 10, day 13 and day 14
To assess the maintenance of cure over time: To compare cure rates between subjects treated with Nix Creme Rinse and the medical device X92001483 at interim visits in order to evaluate the presence and persistence of the preventive effect of the investigational product relative to standard of care product (Nix creme rinse) alone.
Time frame: 14 days
Characterize the time to re-infestation in each treatment group
Time frame: Day 0, day 3, day 7, day 10, days 13, day 14
To compare the number of live lice detected at each assessment across treatment groups.
Time frame: day 0, day 3, day 7, day 10, day 13 and day 14
To evaluate the local tolerability of the standard of care product and investigational product, as measured by subject reported symptoms (eg: burning, paraesthesia, pruritus) following application.
Time frame: day 0, day 3, day 4, day 7, day 10, day 13 and day 14
To evaluate scalp and skin irritation by study staff (secondary infection, erythema, excoriation) following product application.
Time frame: Day 0, day 3, day 7, day 10, day 13 and day 14
To record and characterize all treatment-emergent adverse events occurring during the study.
Contact information is provided by the study sponsor or research team.
Oystershell NV
Industry
In Vivo Testing : A Two-Arm, Randomized, Controlled, Investigator/Assessor-Blinded, Comparative Study to Evaluate the Safety, Efficacy, and Preventative Effect of a Head Lice Physically Acting Product: 2 in 1 SHAMPOO EU VERSION (X92001483) vs NIX CREME RINSE (1% Permethrin) in Subjects With Head Lice.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07244523
Ectoparasitic Infestations, Infections
View Trial DetailsNCT03257943
Ectoparasitic Infestations, Infections
Hawthorne, New York, United States
View Trial DetailsNCT05565820
Ectoparasitic Infestations, Head Lice
Miami, Florida, United States
View Trial DetailsNCT02974088
Ectoparasitic Infestations, Head Lice
Cambridge, United Kingdom
View Trial Details